Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Cited In for PubMed (Select 20691429)

1.

Imaging human brown adipose tissue under room temperature conditions with (11)C-MRB, a selective norepinephrine transporter PET ligand.

Hwang JJ, Yeckel CW, Gallezot JD, Aguiar RB, Ersahin D, Gao H, Kapinos M, Nabulsi N, Huang Y, Cheng D, Carson RE, Sherwin R, Ding YS.

Metabolism. 2015 Jun;64(6):747-55. doi: 10.1016/j.metabol.2015.03.001. Epub 2015 Mar 5.

PMID:
25798999
2.

Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.

Rezaei F, Emami M, Zahed S, Morabbi MJ, Farahzadi M, Akhondzadeh S.

Daru. 2015 Jan 15;23:2. doi: 10.1186/s40199-015-0092-y.

3.

Attention enhancing effects of methylphenidate are age-dependent.

Bhattacharya SE, Shumsky JS, Waterhouse BD.

Exp Gerontol. 2015 Jan;61:1-7. doi: 10.1016/j.exger.2014.11.006. Epub 2014 Nov 11.

PMID:
25449855
4.

Methylphenidate and desipramine combined treatment improves PTSD symptomatology in a rat model.

Aga-Mizrachi S, Cymerblit-Sabba A, Gurman O, Balan A, Shwam G, Deshe R, Miller L, Gorodetsky N, Heinrich N, Tzezana O, Zubedat S, Grinstein D, Avital A.

Transl Psychiatry. 2014 Sep 23;4:e447. doi: 10.1038/tp.2014.82.

5.

Effects of non-pharmacological or pharmacological interventions on cognition and brain plasticity of aging individuals.

Pieramico V, Esposito R, Cesinaro S, Frazzini V, Sensi SL.

Front Syst Neurosci. 2014 Sep 2;8:153. doi: 10.3389/fnsys.2014.00153. eCollection 2014. Review.

6.

Neuroanatomic and cognitive abnormalities in attention-deficit/hyperactivity disorder in the era of 'high definition' neuroimaging.

Baroni A, Castellanos FX.

Curr Opin Neurobiol. 2015 Feb;30:1-8. doi: 10.1016/j.conb.2014.08.005. Epub 2014 Sep 15.

PMID:
25212469
7.

Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.

Cheng J, Xiong Z, Duffney LJ, Wei J, Liu A, Liu S, Chen GJ, Yan Z.

Biol Psychiatry. 2014 Dec 15;76(12):953-62. doi: 10.1016/j.biopsych.2014.04.003. Epub 2014 Apr 12.

PMID:
24832867
8.

Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Wood S, Sage JR, Shuman T, Anagnostaras SG.

Pharmacol Rev. 2013 Dec 16;66(1):193-221. doi: 10.1124/pr.112.007054. Print 2014. Review.

9.

Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.

Rubia K, Alegria AA, Cubillo AI, Smith AB, Brammer MJ, Radua J.

Biol Psychiatry. 2014 Oct 15;76(8):616-28. doi: 10.1016/j.biopsych.2013.10.016. Epub 2013 Oct 24. Review.

10.

Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.

Li CS, Potenza MN, Lee DE, Planeta B, Gallezot JD, Labaree D, Henry S, Nabulsi N, Sinha R, Ding YS, Carson RE, Neumeister A.

Neuroimage. 2014 Feb 1;86:306-10. doi: 10.1016/j.neuroimage.2013.10.004. Epub 2013 Oct 10.

11.

Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus.

Pietrzak RH, Gallezot JD, Ding YS, Henry S, Potenza MN, Southwick SM, Krystal JH, Carson RE, Neumeister A.

JAMA Psychiatry. 2013 Nov;70(11):1199-205. doi: 10.1001/jamapsychiatry.2013.399.

12.

Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction.

Konova AB, Moeller SJ, Tomasi D, Volkow ND, Goldstein RZ.

JAMA Psychiatry. 2013 Aug;70(8):857-68. doi: 10.1001/jamapsychiatry.2013.1129.

14.

Distributed effects of methylphenidate on the network structure of the resting brain: a connectomic pattern classification analysis.

Sripada CS, Kessler D, Welsh R, Angstadt M, Liberzon I, Phan KL, Scott C.

Neuroimage. 2013 Nov 1;81:213-21. doi: 10.1016/j.neuroimage.2013.05.016. Epub 2013 May 16.

15.

Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.

Czerniak SM, Sikoglu EM, King JA, Kennedy DN, Mick E, Frazier J, Moore CM.

Harv Rev Psychiatry. 2013 May-Jun;21(3):151-62. doi: 10.1097/HRP.0b013e318293749e. Review.

16.

Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction.

Moeller SJ, Honorio J, Tomasi D, Parvaz MA, Woicik PA, Volkow ND, Goldstein RZ.

Cereb Cortex. 2014 Mar;24(3):643-53. doi: 10.1093/cercor/bhs345. Epub 2012 Nov 16.

17.

Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot study.

Bush G, Holmes J, Shin LM, Surman C, Makris N, Mick E, Seidman LJ, Biederman J.

Psychiatry Res. 2013 Jan 30;211(1):88-91. doi: 10.1016/j.pscychresns.2012.09.004. Epub 2012 Nov 10.

18.

Dopaminergic involvement during mental fatigue in health and cocaine addiction.

Moeller SJ, Tomasi D, Honorio J, Volkow ND, Goldstein RZ.

Transl Psychiatry. 2012 Oct 23;2:e176. doi: 10.1038/tp.2012.110.

19.

Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.

Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer MJ, Simmons A, Rubia K.

Cereb Cortex. 2014 Jan;24(1):174-85. doi: 10.1093/cercor/bhs296. Epub 2012 Oct 9.

20.

Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons.

Bari A, Aston-Jones G.

Neuropharmacology. 2013 Jan;64:53-64. doi: 10.1016/j.neuropharm.2012.07.020. Epub 2012 Jul 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk